catechol has been researched along with ag 538 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Blum, G; Gazit, A; Levitzki, A | 1 |
2 other study(ies) available for catechol and ag 538
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics.
Topics: Adenosine Triphosphate; Animals; Binding, Competitive; Catechols; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; NIH 3T3 Cells; Oxygen; Phosphorylation; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction; Time Factors; Tyrphostins | 2003 |